CNBCEN
A little-known biotech’s high-stakes cancer bet just paid off and its shares doubled
Genmab’s shares have doubled in three months after a string of cancer drug trial wins, strengthening its push to own more of the medicines it develops.
Fresh headlines from around the world. Gaming, politics, technology and everything in between.
Genmab’s shares have doubled in three months after a string of cancer drug trial wins, strengthening its push to own more of the medicines it develops.
"The number of downloads and purchases has *not* doubled."
The Coalition is promising to revive Victoria's native timber industry through the collection and processing of fuel load as part of a new state election pledge.
Allnira republishes accessible articles under owner-declared permissions, with original authors, publishers and image credits. Automatic cloud imports run hourly; open pages check for updates every 15 seconds. Publication delays depend on each feed.